Transgene Biotek informs about standalone financial results

01 Jul 2014 Evaluate

Transgene Biotek has informed about the Standalone Financial Results & a copy of the Auditors Report for the period ended March 31, 2014.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

2.84 0.21 (7.98%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 399.15
Indegene 459.35
CMS Info Systems 300.35
JITF Infralogistics 355.50
Sagility 39.22
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×